{"entity":{"type":"insider","cik":"0001651844","url":"/insider/0001651844","json_url":"/insider/0001651844.json","name":"Robinson James George","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":380,"n_filings":91,"first":"2015-09-08","last":"2023-06-26","span_basis":"filed_date"},"name_variants":[{"name":"Robinson James George","source":"filing","n_filings":91,"first_seen":"2015-09-08","last_seen":"2023-06-26"}],"transactions":[{"id":9295511,"accession":"0001729637-23-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001729637-23-000006","line_url":"/filing/0001729637-23-000006#line-2","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":18800.0,"total_display":"18,800.00","total_whole":"18,800","shares_owned_after":4782065.0,"shares_owned_after_display":"4,782,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-06-26","scope":"insider"},{"id":8270374,"accession":"0001729637-23-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001729637-23-000001","line_url":"/filing/0001729637-23-000001#line-2","is_derivative":false,"issuer_cik":"0001575295","issuer_name":"Allied Corp.","issuer_ticker":"ALID","issuer_name_source":null,"issuer_url":"/issuer/0001575295","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":18800.0,"total_display":"18,800.00","total_whole":"18,800","shares_owned_after":4782065.0,"shares_owned_after_display":"4,782,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-04-27","scope":"insider"},{"id":9295512,"accession":"0001729637-23-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001729637-23-000006","line_url":"/filing/0001729637-23-000006#line-1","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":4742065.0,"shares_owned_after_display":"4,742,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-06-26","scope":"insider"},{"id":9295510,"accession":"0001729637-23-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001729637-23-000003","line_url":"/filing/0001729637-23-000003#line-1","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":4742065.0,"shares_owned_after_display":"4,742,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-05-18","scope":"insider"},{"id":8270369,"accession":"0001729637-23-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001729637-23-000001","line_url":"/filing/0001729637-23-000001#line-1","is_derivative":false,"issuer_cik":"0001575295","issuer_name":"Allied Corp.","issuer_ticker":"ALID","issuer_name_source":null,"issuer_url":"/issuer/0001575295","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":4742065.0,"shares_owned_after_display":"4,742,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-04-27","scope":"insider"},{"id":6402040,"accession":"0001640334-22-000918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640334-22-000918","line_url":"/filing/0001640334-22-000918#line-1","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1151515.0,"shares_display":"1,151,515","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":1899999.75,"total_display":"1,899,999.75","total_whole":"1,900,000","shares_owned_after":4702065.0,"shares_owned_after_display":"4,702,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-06","scope":"insider"},{"id":5012203,"accession":"0001651844-21-000001","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001651844-21-000001","line_url":"/filing/0001651844-21-000001","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27000.0,"shares_display":"27,000","price_per_share":2.082049448148148,"price_display":"2.08","price_state":"stated","total_value":56215.3351,"total_display":"56,215.34","total_whole":"56,215","shares_owned_after":3530550.0,"shares_owned_after_display":"3,530,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-22","filed_date":"2021-04-27","scope":"insider","n_lines":10},{"id":5012155,"accession":"0001651844-21-000001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001651844-21-000001","line_url":"/filing/0001651844-21-000001","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":2.081366923076923,"price_display":"2.08","price_state":"stated","total_value":27057.77,"total_display":"27,057.77","total_whole":"27,058","shares_owned_after":3518550.0,"shares_owned_after_display":"3,518,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-27","scope":"insider","n_lines":4},{"id":7850872,"accession":"0001651844-19-000023","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001651844-19-000023","line_url":"/filing/0001651844-19-000023","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1.7290821428571428,"price_display":"1.73","price_state":"stated","total_value":12103.575,"total_display":"12,103.58","total_whole":"12,104","shares_owned_after":3509384.0,"shares_owned_after_display":"3,509,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-10","filed_date":"2019-07-12","scope":"insider","n_lines":5},{"id":8432582,"accession":"0001651844-19-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001651844-19-000022","line_url":"/filing/0001651844-19-000022#line-1","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1.6286,"price_display":"1.63","price_state":"stated","total_value":11400.2,"total_display":"11,400.20","total_whole":"11,400","shares_owned_after":3503550.0,"shares_owned_after_display":"3,503,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-09","filed_date":"2019-07-10","scope":"insider"},{"id":8044940,"accession":"0001651844-19-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001651844-19-000021","line_url":"/filing/0001651844-19-000021#line-1","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":1.4499,"price_display":"1.45","price_state":"stated","total_value":13049.1,"total_display":"13,049.10","total_whole":"13,049","shares_owned_after":3496550.0,"shares_owned_after_display":"3,496,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-05","filed_date":"2019-07-09","scope":"insider"},{"id":7870163,"accession":"0001651844-19-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001651844-19-000020","line_url":"/filing/0001651844-19-000020#line-1","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":1.5442,"price_display":"1.54","price_state":"stated","total_value":12353.6,"total_display":"12,353.60","total_whole":"12,354","shares_owned_after":3487550.0,"shares_owned_after_display":"3,487,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-03","filed_date":"2019-07-03","scope":"insider"},{"id":8044937,"accession":"0001651844-19-000019","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001651844-19-000019","line_url":"/filing/0001651844-19-000019","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":1.3672483444444445,"price_display":"1.37","price_state":"stated","total_value":12305.2351,"total_display":"12,305.24","total_whole":"12,305","shares_owned_after":3477556.0,"shares_owned_after_display":"3,477,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-02","scope":"insider","n_lines":8},{"id":8627482,"accession":"0001651844-19-000018","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001651844-19-000018","line_url":"/filing/0001651844-19-000018","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8890.0,"shares_display":"8,890","price_per_share":16.865129358830146,"price_display":"16.87","price_state":"stated","total_value":149931.0,"total_display":"149,931.00","total_whole":"149,931","shares_owned_after":3464815.0,"shares_owned_after_display":"3,464,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-29","filed_date":"2019-07-01","scope":"insider","n_lines":5},{"id":8627466,"accession":"0001651844-19-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001651844-19-000018","line_url":"/filing/0001651844-19-000018#line-1","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1110.0,"shares_display":"1,110","price_per_share":1.475,"price_display":"1.48","price_state":"stated","total_value":1637.25,"total_display":"1,637.25","total_whole":"1,637","shares_owned_after":3461660.0,"shares_owned_after_display":"3,461,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-07-01","scope":"insider"},{"id":8680228,"accession":"0001651844-19-000017","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001651844-19-000017","line_url":"/filing/0001651844-19-000017","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":1.5581333333333334,"price_display":"1.56","price_state":"stated","total_value":14023.2,"total_display":"14,023.20","total_whole":"14,023","shares_owned_after":3459550.0,"shares_owned_after_display":"3,459,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-27","filed_date":"2019-06-28","scope":"insider","n_lines":5},{"id":8561321,"accession":"0001651844-19-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001651844-19-000016","line_url":"/filing/0001651844-19-000016#line-1","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":13680.0,"total_display":"13,680.00","total_whole":"13,680","shares_owned_after":3451550.0,"shares_owned_after_display":"3,451,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-27","scope":"insider"},{"id":8355956,"accession":"0001651844-19-000015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001651844-19-000015","line_url":"/filing/0001651844-19-000015#line-3","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7400.0,"shares_display":"7,400","price_per_share":1.725,"price_display":"1.72","price_state":"stated","total_value":12765.0,"total_display":"12,765.00","total_whole":"12,765","shares_owned_after":3441950.0,"shares_owned_after_display":"3,441,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-25","filed_date":"2019-06-26","scope":"insider"},{"id":8355953,"accession":"0001651844-19-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001651844-19-000015","line_url":"/filing/0001651844-19-000015#line-2","is_derivative":false,"issuer_cik":"0001018735","issuer_name":"NYMOX PHARMACEUTICAL CORP","issuer_ticker":"NYMX","issuer_name_source":null,"issuer_url":"/issuer/0001018735","owner_cik":"0001651844","owner_name":"Robinson James George","owner_display_name":"Robinson James George","owner_url":"/insider/0001651844","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":1.7299,"price_display":"1.73","price_state":"stated","total_value":2421.86,"total_display":"2,421.86","total_whole":"2,422","shares_owned_after":3443550.0,"shares_owned_after_display":"3,443,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-25","filed_date":"2019-06-26","scope":"insider"}],"collapsed":true,"next_cursor":"2019-06-25|8355953","ledger_fault":false,"count":{"value":380,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":380,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":380},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001018735","name":"NYMOX PHARMACEUTICAL CORP","url":"/issuer/0001018735","role":"Director, Ten percent owner","n_filings":90,"first_seen":"2015-09-08","last_seen":"2023-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001575295","name":"Allied Corp.","url":"/issuer/0001575295","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2023-04-27","last_seen":"2023-04-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001651844","retrieved_at":"2026-08-24T11:34:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}